找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Choroidal Neovascularization; Jay Chhablani Book 2020 Springer Nature Singapore Pte Ltd. 2020 Neovascular age-related macular degeneration

[復(fù)制鏈接]
41#
發(fā)表于 2025-3-28 14:47:12 | 只看該作者
42#
發(fā)表于 2025-3-28 20:18:56 | 只看該作者
Dystrophy-Related Choroidal Neovascularizationing perspective on the evolution of the disease and the efficacy of the therapy. This chapter reviews the less prevalent reports of CNV related to hereditary chorioretinal dystrophies and pools evidence on the success and limitations of a variety of therapies.
43#
發(fā)表于 2025-3-28 22:56:09 | 只看該作者
Pachychoroid-Related Choroidal Neovascularizationavation, and peripapillary pachychoroid syndrome have been included in the pachychoroid disease spectrum. Herein, we describe the etiopathogenesis, clinical and imaging features, and treatment options of pachychoroid neovasculopathy.
44#
發(fā)表于 2025-3-29 05:26:38 | 只看該作者
45#
發(fā)表于 2025-3-29 08:21:43 | 只看該作者
46#
發(fā)表于 2025-3-29 12:30:45 | 只看該作者
47#
發(fā)表于 2025-3-29 17:58:50 | 只看該作者
MedR Schriftenreihe Medizinrechtepithelium-derived factor as well as degradation of extracellular matrix are also important factors for the development of CNV. Transgenic and knockout studies have provided important insights into the development of CNV, the main cause of vision impairment and loss in patients with age-related macular degeneration.
48#
發(fā)表于 2025-3-29 20:51:23 | 只看該作者
49#
發(fā)表于 2025-3-30 02:29:36 | 只看該作者
Pathogenesis of Choroidal Neovascularizationepithelium-derived factor as well as degradation of extracellular matrix are also important factors for the development of CNV. Transgenic and knockout studies have provided important insights into the development of CNV, the main cause of vision impairment and loss in patients with age-related macular degeneration.
50#
發(fā)表于 2025-3-30 06:33:30 | 只看該作者
Management Strategies for Neovascular AMDof the disorder and disease stage, as well as the recovery potential, are crucial factors in order to make sensible treatment decisions and avoid overtreatment..Finally, medical advances are about to give access to additional and hopefully better treatment options in the future. A few of these are briefly discussed at the end of this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 23:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永春县| 齐齐哈尔市| 金阳县| 本溪| 九寨沟县| 阳东县| 景洪市| 隆回县| 福清市| 张北县| 隆回县| 车险| 朔州市| 秀山| 南雄市| 固镇县| 鄄城县| 宁城县| 南召县| 双鸭山市| 镇宁| 通城县| 牡丹江市| 攀枝花市| 贺兰县| 海宁市| 马关县| 安阳县| 大田县| 定陶县| 皮山县| 灵璧县| 昌图县| 太仓市| 镇宁| 道真| 吉隆县| 隆化县| 苏州市| 衡南县| 茌平县|